Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
44.90
+2.29 (5.37%)
At close: Dec 5, 2025, 4:00 PM EST
45.00
+0.10 (0.22%)
After-hours: Dec 5, 2025, 7:55 PM EST
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.87 billion as of December 5, 2025. Its market cap has decreased by -1.24% in one year.
Market Cap
2.87B
Enterprise Value
2.45B
1-Year Change
-1.24%
Ranking
Category
Stock Price
$44.90
Market Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.87B, an increase of 1,174.18%. That is a compound annual growth rate of 74.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.87B | 7.19% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | 225.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |